Search for Clinical Trial Results
Neuroblastoma - 49 Studies Found
| Status | Study |
| Completed |
Study Name: Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma Condition: Neuroblastoma Date: 1999-11-01 Interventions: Drug: becatecarin |
| Completed |
Study Name: Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma Condition: Neuroblastoma Date: 1999-11-01 Interventions:
|
| Completed |
Study Name: Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma Condition: Neuroblastoma Date: 1999-11-01 Interventions:
|
| Completed |
Study Name: Surgery in Treating Children With Neuroblastoma Condition: Neuroblastoma Date: 1999-11-01 Interventions:
|
| Completed |
Study Name: Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET) Condition: Neuroblastoma Date: 2011-02-22 Interventions: Device: FLT-PET PET scan will be conducted at diagnosis, at the end of the first cycle of treatment and |
| Completed |
Study Name: Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide Condition: Neuroblastoma Date: 2010-01-26 Interventions:
|
| Completed |
Study Name: Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma Condition: Neuroblastoma Date: 2002-05-13 Interventions:
|
| Completed |
Study Name: Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma Condition: Neuroblastoma Date: 2007-03-20 Interventions:
|
| Completed |
Study Name: Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma Condition: Neuroblastoma Date: 2001-10-11 Interventions:
|
| Active, not recruiting |
Study Name: N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma Condition: Neuroblastoma Date: 2009-04-18 Interventions:
|